HOME DEPOT, INC.

**Signal Note: Eventide Values Position in Home Depot** This move is notable primarily as a portfolio diversification signal rather than a biotech catalyst—Eventide's entry into HD (a non-healthcare holding) suggests either cash deployment from biotech underperformance or a tactical shift toward defensive consumer discretionary exposure. The $11.7M position size represents material capital reallocation from a manager typically concentrated in life sciences, warranting monitoring of whether this reflects conviction in HD's valuation or reduced conviction in the biotech pipeline.